Royal London Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294M Buy
1,202,690
+61,420
+5% +$14.3M 0.62% 20
2025
Q4
$236M Buy
1,141,270
+33,876
+3% +$6.7M 0.5% 32
2025
Q3
$205M Buy
1,107,394
+157,275
+17% +$26.9M 0.44% 38
2025
Q2
$145M Sell
950,119
-669,845
-41% -$103M 0.33% 55
2025
Q1
$269M Sell
1,619,964
-6,848
-0.4% -$1.07M 0.64% 27
2024
Q4
$235M Buy
1,626,812
+17
+0% +$2.63K 0.57% 29
2024
Q3
$264M Buy
1,626,795
+31,334
+2% +$4.99M 0.65% 26
2024
Q2
$233M Sell
1,595,461
-101,078
-6% -$15M 0.6% 31
2024
Q1
$268M Buy
1,696,539
+76,940
+5% +$12.2M 0.67% 28
2023
Q4
$254M Buy
1,619,599
+53,116
+3% +$8.14M 0.73% 26
2023
Q3
$244M Sell
1,566,483
-117,348
-7% -$19.4M 0.79% 26
2023
Q2
$279M Buy
1,683,831
+297,638
+21% +$48M 0.9% 23
2023
Q1
$215M Buy
1,386,193
+169,687
+14% +$27.4M 0.86% 20
2022
Q4
$215M Buy
1,216,506
+26,875
+2% +$4.64M 0.96% 21
2022
Q3
$195M Sell
1,189,631
-60,645
-5% -$10.3M 0.99% 15
2022
Q2
$222M Sell
1,250,276
-6,905
-0.5% -$1.23M 1.03% 16
2022
Q1
$223M Buy
1,257,181
+47,031
+4% +$8M 0.87% 20
2021
Q4
$207M Sell
1,210,150
-60,228
-5% -$9.86M 0.77% 27
2021
Q3
$205M Sell
1,270,378
-76,807
-6% -$13.1M 0.83% 22
2021
Q2
$222M Sell
1,347,185
-92,544
-6% -$15.3M 0.91% 19
2021
Q1
$237M Sell
1,439,729
-169,688
-11% -$27.5M 1.08% 16
2020
Q4
$253M Sell
1,609,417
-1,221
-0.1% -$180K 1.33% 10
2020
Q3
$237M Buy
1,610,638
+154,259
+11% +$22.8M 1.43% 10
2020
Q2
$203M Sell
1,456,379
-59,138
-4% -$8.62M 1.42% 9
2020
Q1
$201M Buy
1,515,517
+17,114
+1% +$2.43M 1.63% 6
2019
Q4
$218M Buy
1,498,403
+34,215
+2% +$4.64M 1.51% 8
2019
Q3
$189M Sell
1,464,188
-656
-0% -$86.4K 1.43% 8
2019
Q2
$204M Buy
1,464,844
+20,313
+1% +$2.81M 1.93% 6
2019
Q1
$202M Sell
1,444,531
-424,782
-23% -$56.9M 1.59% 7
2018
Q4
$199M Buy
1,869,313
+648,775
+53% +$90.5M 1.75% 5
2018
Q3
$169M Sell
1,220,538
-20,248
-2% -$2.69M 1.73% 6
2018
Q2
$151M Buy
+1,240,786
New +$155M 1.51% 7
2016
Q2
$122M Sell
1,009,121
-71,615,896
-99% -$8.14B 2% 5
2016
Q1
$671K Buy
72,625,017
+71,606,645
+7,031% +$7.41B 0.96% 18
2015
Q4
$106M Buy
1,018,372
+12,603
+1% +$1.27M 1.63% 5
2015
Q3
$93.9M Buy
+1,005,769
New +$97.3M 1.51% 8
2014
Q4
$976K Buy
926,462
+195,983
+27% +$20.7M 1.84% 3
2014
Q3
$77.8M Buy
730,479
+35,031
+5% +$3.63M 1.95% 3
2014
Q2
$70M Sell
695,448
-2,783
-0.4% -$281K 1.61% 4
2014
Q1
$70.2M Buy
698,231
+37,836
+6% +$3.51M 1.63% 3
2013
Q4
$62.6M Buy
660,395
+14,578
+2% +$1.34M 1.59% 6
2013
Q3
$59.6M Buy
645,817
+8,448
+1% +$758K 1.6% 6
2013
Q2
$55.3M Buy
+637,369
New +$54.1M 1.61% 6

Other funds holding JNJ

Royal London Asset Management's JNJ Position: Q1 2026 in Review

Royal London Asset Management increased its Johnson & Johnson (JNJ) stake by 5.4% in Q1 2026, buying an estimated $14.3M and bringing the position to 1,202,690 shares worth $294M. The position accounts for 0.62% of the portfolio, ranked #20.

Royal London Asset Management first reported a position in JNJ in Q2 2013 and has held it in 43 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Royal London Asset Management held 1,202,690 shares of Johnson & Johnson worth $294M as of Q1 2026.
  • Royal London Asset Management bought 61,420 Johnson & Johnson shares in Q1 2026, an estimated $14.3M.
  • Johnson & Johnson made up 0.62% of Royal London Asset Management's portfolio in Q1 2026, its #20 holding.
  • Royal London Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 43 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.